Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Giving drugs in different ways may kill more tumor cells. It is not
yet known whether giving vinorelbine by mouth or infusion is more effective in treating non-
small cell lung cancer.
PURPOSE: Randomized phase II trial to compare the effectiveness of vinorelbine given by mouth
or as an infusion in treating patients who have stage IIIB or stage IV non-small cell lung
cancer.